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The brain is hypothermic in patients with mitochondrial diseases 
Mario Rango1,2, Andrea Arighi1,2, Cristiana Bonifati1,2, Roberto Del Bo1, Giacomo Comi1 and Nereo Bresolin1,2 
We sought to study brain temperature in patients with mitochondrial diseases in different functional states compared with healthy 
participants. Brain temperature and mitochondrial function were monitored in the visual cortex and the centrum semiovale at rest 
and during and after visual stimulation in seven individuals with mitochondrial diseases (n ¼ 5 with mitochondrial DNA mutations 
and n ¼ 2 with nuclear DNA mutations) and in 14 age- and sex-matched healthy control participants using a combined approach of 
visual stimulation, proton magnetic resonance spectroscopy (MRS), and phosphorus MRS. Brain temperature in control participants 
exhibited small changes during visual stimulation and a consistent increase, together with an increase in high-energy phosphate 
content, after visual stimulation. Brain temperature was persistently lower in individuals with mitochondrial diseases than in healthy 
participants at rest, during activation, and during recovery, without signiﬁcant changes from one state to another and with a 
decrease in the high-energy phosphate content. The lowest brain temperature was observed in the patient with the most deranged 
mitochondrial function. In patients with mitochondrial diseases, the brain is hypothermic because of malfunctioning oxidative 
phosphorylation. Neuronal activity is reduced at rest, during physiologic brain stimulation, and after stimulation. 
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INTRODUCTION 
Maintaining near-constant brain temperature (Tbr) across a wide 
range of metabolic activity is critical for normal brain function. 
However, brain temperature is an often-ignored parameter in 
neuroscience and clinical studies. 
Animal studies have shown a close relationship between brain 
temperature and cerebral oxygen metabolic rate (CMRO2)
2 at rest 
and during brain activation. There are only fragmentary data 
regarding Tbr and its regulation under different physiologic 
conditions and no temperature data are available regarding 
patients with mitochondrial disorders. Time-dependent variations 
in Tbr are caused by ﬂuctuations of cerebral blood ﬂow (CBF) and 
CMRO , both of which appear to be coupled to changes in 
neuronal activity.1 Increases in CBF reduce Tbr and increases in 
brain metabolism increase Tbr. 
Intense heat production is an essential feature of normal brain 
energetics; most of the energy used for brain functioning is 
eventually released as heat.4 In the brain, heat is produced mostly 
by mitochondrial oxidative chemical reactions. Most of the energy 
required for brain activity is generated from the net chemical 
reaction of oxygen and glucose; some of this energy (33%) is 
immediately dissipated into heat, and the rest (67%) is used to 
synthesize ATP. The ﬁnal ATP hydrolysis releases part of the 
energy back to the system as heat.4 
Owing to rapid ATP turnover and the high cerebral metabolic rate 
of oxygen, basal heat production within the brain is high. Aerobic 
metabolism of glucose produces heat at a rate of 0.7 J/min per gram 
brain tissue.4 In a closed system, this metabolism would lead to an 
increase in temperature of 0.281C/min. However, because the brain 
is an ‘open’ thermodynamic system, heat is dissipated through 
circulation and by conduction through the skull. Most of the heat is 
dissipated through CBF, with venous blood leaving the brain at a 
higher temperature than the incoming arterial blood.1,4 
Mitochondrial diseases are characterized by dysfunctions of 
mitochondria and energetics. In these diseases, cellular dysfunc-
tions arise from disordered energy metabolism (i.e., failure of the 
respiratory chain to produce ATP). Primary (point mutations in 
mitochondrial DNA (mtDNA)) and secondary (e.g., due to poly-
merase gamma—POLG—mutations) mtDNA defects disrupt the 
formation of one or more mitochondrially encoded respiratory 
chain subunits, leading to respiratory chain dysfunction and 
compromised energy-generating capacity. As a consequence, the 
amount of heat released owing to brain metabolism is usually 
reduced.5,6 
Some patients with mitochondrial disease appear to have 
problems regulating body temperature at higher or lower ambient 
temperatures, and exposure to cold can result in severe heat loss 
and trigger an energy crisis.5,6 
Mitochondrial diseases are heterogeneous and often multi-
systemic. Because the mitochondrion provides much of the 
energy for the cell, mitochondrial disorders preferentially affect 
tissues with high-energy demands, such as the brain, although 
any organ can be affected.5,6 
Thus, energetic defects have been implicated in forms of 
blindness, deafness, movement disorders, dementias, cardiomyo-
pathy, myopathy, renal dysfunction, and aging.5,6 
Mitochondrial diseases can be caused by genetic defects in any 
mtDNA or nuclear DNA (nDNA) gene that encodes a mitochondrial 
protein or structural RNAs. Given the energetics impairment, brain 
temperature is likely affected in mitochondrial diseases. 
Most physical and chemical processes are affected by 
temperature, with the average van’t Hoff coefﬁcient Q10 ¼ 2.34 
and temperature inﬂuences several biochemical and physiologic 
parameters involved in brain temperature control.1 Indeed, in 
studies on brain slices, temperature increases enhanced oxygen 
metabolism.7 
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functional conditions (i.e., at rest, during functional activation, and 
after activation) in patients affected by mitochondrial citopathies 
and in control participants for comparison. We planned a study in 
which Tbr was observed with a large temporal window, serially, 
across these different functional states in the visual cortex using a 
noninvasive visual stimulation-1-H magnetic resonance spectro- 
scopy (1-H MRS) combined approach. We used 1-H MRS because it 
is the most reliable noninvasive brain thermometry method.1 We 
observed mitochondrial function using 31-P MRS under the same 
conditions.16 
PATIENTS AND METHODS 
Patient Population 
The study included ﬁve patients (two men, three women; mean age 46 
years (s.d. 11)) with mitochondrial disease with mtDNA mutation without 
clinical central nervous system involvement (MDW/mtDNA) (Table 1). All 
participants had chronic progressive external ophthalmoplegia with or 
without limb myopathy. In all cases, the diagnosis of MDW/mtDNA was 
based on the clinical examination and the combined ﬁndings of histology, 
biochemical analysis, and genetic analysis of muscle biopsy specimens.16 
Southern blot analysis was performed on a muscle biopsy from each 
patient. Patients with single mtDNA deletion were selected (Table 1), and 
only patients with a quantiﬁed amount of mtDNA deletion between 40% 
and 60% were included in the study. 
Full ophthalmologic and neurologic examinations, T1- and T2-weighted 
magnetic resonance imaging (MRI) brain studies and electroencephalo-
graphy were performed to exclude patients with any of the following: 
symptoms or signs of central nervous system involvement on neurologic 
examination, abnormal brain MRI studies, abnormal electroencephalo-
gram, and abnormal ophthalmologic examinations (except for ptosis or 
impaired ocular motility). Patients with other diseases and patients taking 
drugs of any kind were also excluded. 
Two patients with nuclear mitofusin 2 gene (MFN2) mutation with 
clinical peripheral and central nervous system involvement (MD/nDNA) 
were also included in the study (Table 1).17 They were father and son, and 
both had mild cognitive impairment and peripheral neuropathy. The 
diagnosis of MD/nDNA was based on the clinical examination and the 
combined ﬁndings of histology, biochemical analysis, and genetic analysis 
of nerve biopsy specimens and blood.16,17 All MFN2 gene exons were 
analyzed on leukocyte-derived DNA as described.17 The coding exons of 
Berardinelli-Seip congenital lipodystrophy type 2 (BSCL2), vesicle-
associated membrane protein associated protein B (VAPB), senataxin 
(SETX), glycyl-tRNA synthetase (GARS), and optic atrophy-1 (OPA1) genes 
were also sequenced.17 The entire mtDNA sequence was analyzed from 
blood-derived DNA. 
Fourteen control participants matched with MDW and MD patients for 
age (mean age 43 years, s.d. 11) and sex (8 men and 6 women) were 
studied. Each patient was matched with two control participants of the 
same age (age difference o5 years) and sex. Control participants were 
deﬁned as having no history of neurologic disease, no history of major 
disease, normal neurologic and ophthalmologic examinations, and normal 
T1- and T2-weighted brain MRI; they were also not taking any drugs. The 
ﬁve oldest control participants also underwent pattern reversal visual-
evoked potential, with normal results. Vascular risk factors were excluded. 
Table 1. Patient information 
Patient no. Clinical phenotype Age (years) DNA mutation 
1 
2 
3 
4 
5 
6 
26 
43 
47 
65 
51 
42 
7 
CPEO 
CPEO, limb myopathy 
CPEO, limb myopathy 
CPEO, limb myopathy 
CPEO 
Peripheral neuropathy, optic neuropathy, 
cognitive impairment 
Peripheral neuropathy, cognitive impairment 10 
mtDNA common deletion 
mtDNA common deletion 
mtDNA common deletion 
mtDNA single deletion (12,112–14,442) 
mtDNA single deletion (6,900–12,500) 
Nuclear DNA MFN2 heterozygous exon 4 nucleotide 
substitution (c.310C4T) 
Nuclear DNA MFN2 heterozygous exon 4 nucleotide 
substitution (c.310C4T) 
CPEO, chronic progressive external ophthalmoplegia; mtDNA, mitochondrial DNA. For single deletion, the deleted region in mitochondrial DNA (nucleotides) 
is reported in parentheses. 
Neuronal activity is temperature dependent, with neuronal 
ﬁring increasing with increased temperature.1,8     Accordingly, 
decreasing temperature modiﬁes neuronal activity in the visual 
cortex; in fact, studies of visual cortex neurons have shown that 
cooling (from 351C to 211C) decreases the membrane potential 
(1.0 to 2.0 mV/11C) and increases the input resistance (B2MO/11C), 
bringing the cells closer to the spiking threshold. Cooling also 
strongly increases the spike duration (from 1.3 ms at 321C to 
5.1 ms at 201C).9 
Studies of the visual cortex have also revealed various effects of 
temperature changes on passive membrane properties, single 
neuronal spikes, and spike bursts, as well as on the neuronal 
responses induced by direct and indirect electrical stimulation of 
tissue or its afferent pathways.1,8–10 
Small temperature variations affect protein conformation and 
assembly and alter protein expression.1,10 Temperature also 
strongly modulates neurotransmitter release.1,11 
The brain is the most heat-sensitive organ in the human body,1 
and mitochondrial and plasma membranes are the most 
temperature-sensitive cellular elements, with hyperthermia 
potentiating the cytotoxic effects of reactive oxygen species.1,10 
Febrile temperature (401C) activates mitochondrial energy-
supplying functions; further temperature increase by only a few 
degrees leads to severe impairment of mitochondrial ability to 
maintain the membrane potential and synthesize ATP. 
Less is known on how increased brain activity inﬂuences 
temperature. During functional stimulation, the major factors 
contributing to Tbr regulation are changes in oxygen consumption, 
CBF, and the temperature of incoming arterial blood, as well as 
extensive heat exchange between the activated area and the 
surrounding brain tissue.1 Cerebral blood ﬂow , brain metabolism, 
and oxygen extraction all increase, that is, mechanisms that 
reduce heat work together with other mechanisms that increase 
local heat. As a consequence, the net heat balance, or Tbr, is 
difﬁcult to predict under these conditions because these changes 
do not occur simultaneously. Brain temperature measurement in 
animals and humans has yielded data that show either an increase 
or a decrease12–15 in temperature during stimulation. Sensory 
stimulation results in Tbr changes in either direction, partly 
depending on anatomic localization and these observations, 
altogether indicate that there may be variations, regarding both 
polarity and size, in the Tbr due to brain activation. No consistent 
experimental data or mathematical modeling is available 
regarding Tbr in the postactivation/recovery phase. 
In control participants, mitochondrial function changes in a 
predictable manner during rest, brain stimulation/activation, and 
recovery from activation.4,16 Instead, brain temperature changes 
under the same conditions are less well known in control parti-
cipants and completely unknown in patients with mitochondrial 
diseases. Given their likely interdependence, we studied both 
brain temperature and mitochondrial function during different 
Visual Stimulation 
The method used to deliver visual stimulation has been fully described.16 
In brief, it was delivered by goggles (Grass) that ﬂashed at 8 Hz to 
reproduce the stimulation pattern used in a previous work.16 The authors 
used an infrared-driven computerized system that was developed 
connected to the magnetic resonance (MR) system computer, through 
which goggles were automatically turned on after 6.5-minute acquisition 
and turned off after 13-minute acquisition. 
Spectra were acquired at rest (ﬁrst 6.5 minutes), during visual stimulation 
(next 6.5 minutes) and during recovery from visual activation (next 
6.5 minutes). 
Body Temperature Measurement 
Axillary body temperature was measured with a mercury-in-glass 
thermometer in patients and in control participants. No febrile participant 
at the time of the study (body temperature 4371C) was included in the 
study. Participants sat in the waiting hall of the MRI unit for 60 minutes 
before their MRS assessment to ensure proper adaptation. The hall’s 
temperature was maintained at 221C throughout all assessment periods. 
The magnet temperature was maintained at 221C. 
All studies were performed on the same day of the week between 1400 
and 1600 h. 
Brain Temperature Measurement using 1H Magnetic Resonance 
Spectroscopy 
19 
All studies were performed on a 1.5T Siemens System (Siemens, Erlangen, 
Germany) using a quadrature detection transmitter/receiver (Tx/Rx) head 
coil. The images were assessed under blinded conditions by an MR expert. 
Magnetic resonance sagittal, axial, and coronal T1 and T2/proton density 
weighted images were acquired. 
Single-voxel 1H-MRS spectra were acquired without water suppression 
from a volume of interest (20 _ 20 _ 10 mm) aligned along the calcarine 
scissure of the occipital cortex and in the left centrum semiovale. A point-
resolved spectroscopy sequence was used. The acquisition parameters 
were repetition time 2,000 ms, echo time 270 ms, 32 acquisitions, 1,024 
points per spectrum, and 1,000 Hz spectral width. 
Spectra were acquired at rest (baseline condition), during visual 
stimulation, and after the end of visual stimulation. Two spectra from 
the visual cortex were acquired (spectrum mid-acquisition time) 2 minutes 
after and 5 minutes after the beginning of each state. Similarly, two spectra 
were acquired from the centrum semiovale after the beginning of each 
state. The two temperature values obtained from the resting state were 
averaged to obtain a single value. 
All spectra were inspected visually ﬁrst, and discarded if they were 
judged to be of poor quality (e.g., had a badly elevated baseline or 
contained spurious peaks). Spectra were also discarded if linewidths at half 
maximum were 48 Hz or if the metabolite peaks were offset from their 
expected values by 40.1 p.p.m. Data processing included Lorentzian 
ﬁltering (1 Hz line broadening), Fourier transformation, and automatic 
phase correction. 
A typical spectrum obtained from the visual cortex is displayed in 
Figure 1. The temperature calculation was based on the measured 
difference between the water resonance frequency, which is linearly 
temperature dependent, and the N-acetyl aspartate (NAA) methyl 
resonance frequency, which remains stable at different temperatures.18,19 
Absolute values of Tbr (expressed in 1C) were calculated according to the 
equation T1 ¼ 228.2ÿ 72.2 _ (dH2O ÿ dNAA), where dH2O and dNAA are the 
resonance frequencies expressed in p.p.m., measured at the center of the 
water-ﬁtted and NAA-ﬁtted peaks. We employed a time domain analysis 
using the jMRUI software (URL http://www.mrui.uab.es/mrui/). The water 
and NAA signal were modeled as mono-exponentially decaying sinusoids 
using the Hankel Lanczos Total Least Squares (HLTLS) algo-
rithm20 and their resonance frequency estimated. The digital sensitivity 
of this MR thermometry method is 0.0103 p.p.m./11C. The actual measured 
sensitivity is within 0.201C (see Supplementary File 1). The actual measured 
accuracy is within 0.201C (see Supplementary File 1) as well. For these 
reasons, we rounded brain temperature values at 0.201C steps. 
31-P Magnetic Resonance Spectroscopy Spectra 
Spectra were obtained from the visual cortex and analyzed as described 
previously.16      The phosphocreatine þ bATP variable, a measure of 
mitochondrial function,16 was calculated by peak integration and then 
used for the following calculations. The values were normalized to the 
reference compound signal and expressed in arbitrary units.16 For the 
purpose of the study, the stimulation 1 and stimulation 2 periods were 
lumped together, as were the recovery 1 and recovery 2 periods. 
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Figure 1. Visual cortex spectrum and brain temperature. 1H 
magnetic resonance (MR) unﬁtted spectrum (B) obtained from a 
voxel of 20 _ 20 _ 10 mm centered on the calcarine scissure of a 
healthy volunteer (A). Spectra acquisition parameters: point-
resolved spectroscopy sequence (PRESS), repetition time (TR) 
2,000 ms, echo time (TE) 270 ms. The MR signals corresponding to 
water (H O) and N-acetyl-aspartate (NAA) are identiﬁed. Brain 
temperature is obtained by measuring the resonance frequency of 
H O and NAA, according to the formula T1 ¼ 228.2–72.2 _ (d ÿ 
d ), where T1 is temperature in degree Celsius and d and d 
are the resonance frequencies expressed in p.p.m., measured at the 
center of the water-ﬁtted and NAA-ﬁtted peaks. The digital 
sensitivity of this MR thermometry method is 0.0103 p.p.m./11C. 
The actual measured sensitivity is within 0.201C (see Supplementary 
File 1). The actual measured accuracy is within 0.201C (see 
Supplementary File 1) as well. For these reasons, we rounded brain 
temperature values at 0.201C steps. 
 
In all subjects ﬂash and pattern reversal visual-evoked potential were 
obtained. The study was approved by both the local and the national 
ethical committees. All study participants provided informed consent in 
accordance with the declaration of Helsinki. 
This project has been approved by the National Institute of Health and 
by the local ethical committee. The procedures followed were in 
accordance with the Ethical Standards of the Fondazione Policlincico, 
IRCCS responsible committee on human experimentation (institutional) 
and with the Helsinki Declaration of 1975 (and as revised in 1983). 
 
Statistics 
Two-tailed t-tests, analysis of variance, and Pearson’s r correlation 
coefﬁcients were used for statistical analysis. Bonferroni’s correction for 
multiple comparisons was applied. All P-values lower than 0.001 were 
rounded at 0.001 and reported as Po0.001. 
RESULTS 
Body Temperature 
The mean body temperature did not differ between patients with 
mitochondrial disease and control participants (36.701C, 0.13 s.d. 
vs. 36.601C, 0.11 s.d., P ¼ n.s.). 
Control Participants 
At rest, the mean Tbr in the visual cortex was 37.401C (s.d. 0.20). At 
2 minutes after the beginning of visual stimulation, the mean Tbr 
was still 37.401C (s.d. 0.20) (P ¼ n.s.) (Figure 2). At 5 minutes, the 
mean Tbr decreased to 37.201C (s.d. 0.20) (0.201C below the 
baseline value, Po0.05) (Figure 2). The mean Tbr at 2 minutes after 
the end of visual stimulation rose signiﬁcantly to 37.801C (s.d. 0.20) 
(0.401C above baseline value, Po0.0001) (Figure 2). At 5 minutes 
after the end of visual stimulation, the mean Tbr returned to 37.401C 
(s.d. 0.20), thus overlapping the baseline value (P ¼ n.s.; Figure 2). 
Analysis of variance did not reveal any mean temperature 
changes in the centrum semiovale across the ﬁve states (rest, 
activation 1, activation 2, recovery 1, and recovery 2) (P ¼ n.s.). At 
rest, the mean Tbr was 37.601C (s.d. 0.20). The mean Tbr was 
37.601C (s.d. 0.20, P ¼ n.s.) at 2 minutes after initiating visual 
stimulation, and 37.601C (s.d. 0.26, P ¼ n.s.) at 5 minutes after 
initiating visual stimulation. At 2 minutes after the end of visual 
stimulation, the mean Tbr was 37.601C (s.d. 0.20, P ¼ n.s.); at 
5 minutes after the end of visual stimulation, the mean Tbr was 
37.601C (s.d. 0.20, P ¼ n.s.). Flash and pattern reversal visual-
evoked potentials were normal in all subjects. 
MDW/Mitochondrial DNA Patients 
At rest, the Tbr in the visual cortex was below the normal range 
(37.001C to 37.801C) in all the ﬁve patients. 
Analysis of variance revealed that the mean Tbr in the visual 
cortex was signiﬁcantly lower in patients with mtDNA mutations 
than in control participants. This was true for all ﬁve functional 
states (rest, visual stimulation 1, visual stimulation 2, recovery 1, 
and recovery 2) (Po0.001; Figure 2). Tbr (in 1C) was at rest, 36.60 
(0.20) vs. 37.40 (0.20) (Po0.001); during the ﬁrst part of visual 
stimulation, 36.60 (0.40) vs. 37.40 (0.20) (Po0.001); during the 
second part of visual stimulation, 36.60 (0.40) vs. 37.20 (0.20) 
(Po0.001); during the ﬁrst part of recovery, 36.60 (0.40) vs. 37.80 
(0.20) (Po0.001); and during the second part of recovery, 36.60 
(0.20) vs. 37.40 (0.20) (Po0.001). 
In the centrum semiovale, the Tbr at rest was below the normal 
range (37.201C to 38.201C) in all ﬁve patients and the mean Tbr at 
rest was lower in patients with mtDNA mutations than in control 
participants: 36.801C (0.40) vs. 37.601C (0.20), Po0.001, unpaired 
t-test. 
MD/Nuclear DNA Patients 
In the visual cortex, the Tbr at rest was below the normal range in 
the two MDW/mtDNA patients (35.80 and 36.40, respectively). In 
the centrum semiovale, the Tbr at rest was also below the normal 
range in the two MDW/mtDNA patients (35.801C and 36.601C, 
respectively). 
At rest, the PCrþ bATP was normal in all mitochondrial patients 
except for patient 6, who had an abnormally low value (Figure 3). 
For this reason and because he had optic neuropathy, the 31-P 
MRS study was performed only at rest in this patient. PCr þ bATP 
remained in the normal range during visual stimulation in the 
other six patients, but decreased below normal during recovery in 
all participants (Figure 3). Spectra from a normal subject and from 
a patient during recovery are shown in Figure 4. 
br 
br 
Figure 2. The mean temperature (±s.d.) of the visual cortex in 
MDW/mtDNA patients and in healthy control participants at rest, 
during visual stimulation, and during recovery after visual stimula-
tion. T remains ﬂat and constantly lower in the MDW/mtDNA 
group than in the healthy control participants. In the control group, 
after a small decrease in the second part of stimulation, T increases 
during the ﬁrst part of recovery. Stimulation 1, ﬁrst part of visual 
stimulation; Stimulation 2, second part of visual stimulation; 
Recovery 1, ﬁrst part of recovery from visual stimulation; Recovery 
2, second part of recovery from visual stimulation. 
Figure 3. Single phosphocreatine (PCr) þ bATP values of patients at 
rest, during visual stimulation, and during recovery. Patient 1, solid 
diamond; Patient 2, solid triangle; Patient 3, x; Patient 4, solid circle; 
Patient 5, þ ; Patient 6, solid square; Patient 7, black bar. For the 
purpose of the study, the two stimulation and two recovery periods 
have each been pooled. The normal range for each condition is 
bounded by the dotted lines. 
 
Visual-Evoked Potential 
Both ﬂash and pattern visual-evoked potentials were recorded. Pattern 
visual-evoked potentials were recorded mono-ocularly to reversal of 
fulﬁlled checkerboards. Check size was 50’. The mean luminescence was 
50 cd/m2 with a contrast of 90%, 128 sweeps were averaged per recording. 
All subjects wore their best refractory correction. The stimulated eye ﬁxed 
a reference point at the center of the monitor, while the other eye was 
blinded by a pad. This setting guaranteed an approximately similar 
luminescence on each eye. The evaluated variable, for the purpose of this 
study, was the P100 latency. 
  
Flash visual-evoked potential was normal in all patients except 
in patient #6. Pattern reversal visual-evoked potentials showed 
increased mean P100 latency in the pooled MDW/mtDNA and 
MD/nDNA patient group (128±14 ms vs. 87±15 ms, Po0.01). A 
negative correlation (Po0.01) between visual cortex rest Tbr and 
P100 latency was found by a Pearson’s r correlation coefﬁcient 
analysis including all seven patients. 
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DISCUSSION 
This is the ﬁrst study observing sequential brain temperature 
variations across functional states in control participants and in 
patients with mitochondrial disorders. We used a large temporal 
window because the time constant of the temperature change is 
several seconds.13 
In control participants, Tbr at rest was higher than body 
temperature in line with previous measurement. The Tbr of the 
stimulated region in control participants ﬁrst remained stable and 
then decreased slightly. These ﬁndings help to explain 
contradictory results of short stimulation studies21 vs. longer 
stimulation studies.22     Although other kinds of stimuli may 
be used, we chose to study the visual cortex because visual 
activation of the brain appears optimal given the high oxidative 
metabolism4,11 and high levels of oxidative phosphorylation 
enzymes in the visual cortex.23 Additionally, visual stimuli can be 
easily graded.24 
Glycolysis, which releases less heat per mole of glucose than 
respiration, appears to prevail during the ﬁrst part of brain 
activation, while respiration prevails during the second part.25 
Although CBF increases signiﬁcantly during functional activation 
and brain metabolism also increases, the exact timing of these 
changes and their relationship are unclear. 
In control participants during activation, our data can be 
explained by a change in the ratio of CBF to glucose metabolism 
(CBF/CMRglu), by a change in the ratio of CBF to oxygen 
metabolism (CBF/CMRO ), or by a change in both within the time 
interval that we observed.25 Cerebral blood ﬂow returns to 
baseline almost immediately after the end of brain activation,26 
2 
br 
2 br 
br 
Figure 4. 31-P spectra from a control subject and from a patient 
during recovery from visual activation. Spectra acquisition/proces-
sing parameters: sweep width ¼ 2,000 Hz, 2,048 digitalized points, 
convolution difference to remove broad signal (exponential line 
broadening ¼ 150 Hz), exponential multiplication (20 Hz) to improve 
signal-to-noise ratio, and no baseline correction. Please, note that 
both phosphocreatine (0 p.p.m.) and bATP ( ÿ 19 p.p.m.) peaks are 
lower in the patient than in the control subject (whereas they 
started from similar values at rest, not shown here). 
 
 
while oxygen metabolism and glucose metabolism remain 
elevated.27 As a result, an excess of heat is released from the 
brain that is not adequately removed by increased CBF. This 
situation causes the Tbr to increase during the ﬁrst part of the 
postactivation phase, with a return toward baseline values during 
the second part when oxygen metabolism decreases.26 This is the 
ﬁrst report to show that in humans Tbr increases after activation is 
over (i.e., after the end of increased neuronal ﬁring). 
This ﬁnding has several physiologic implications. First, during 
neuronal ﬁring there is little heat release. Second, there is an 
aftermath of increased brain activity that extends for several 
minutes beyond the activation phase itself; this aftermath is 
dynamic, with a progressive return to baseline conditions. This 
information must be taken into account if a new stimulus is 
delivered to the brain before a proper postactivation/recovery 
interval is observed: in this case, the starting conditions differ from 
when a proper postactivation interval is observed. 
Lack of a proper postactivation interval happens in everyday 
life; for example, driving a car at night on the highway or dancing 
with stroboscopic lights implies a great amount of closely 
repeated visual stimulation that is not present when resting in 
bed with the lights off.28 It is also the case for most experimental 
studies with averaged prolonged stimulation blocks, since they 
usually observe too short (subminute) interstimulation intervals.29 
This is especially important in blood oxygen level-dependent 
magnetic resonance studies, as oxygen release from hemoglobin 
is temperature dependent and a change in blood oxygen level-
dependent signal may actually reﬂect temperature changes.29,30 
The change of 0.601C that we observed in the visual cortex 
between the second part of visual stimulation and the ﬁrst part of 
recovery represents, physiologically, a very consistent temperature 
change in a short time, which may strongly inﬂuence brain 
function since the increase in brain temperature increases neuronal 
ﬁring.1,8 There may be also consequences to CBF of changes in 
brain temperature. In fact, there is some evidence that selective 
brain cooling increases CBF above control levels and vice versa.31 
In patients with mitochondrial diseases Tbr at rest is decreased. 
Indeed, except for a single instance of ATP synthase deﬁciency, 
mitochondrial diseases are characterized by reduced brain CMRO 
at rest with reduced heat release.32,33 This way, body temperature 
and brain temperature overlap because brain temperature cannot 
be kept elevated by the consistent production of heat by the 
brain, as in control participants. Indeed, in our study the lowest Tbr 
was observed in the patient (#6) with the most deranged 
respiratory chain (i.e., the patient whose brain high-energy 
phosphates were already reduced at rest). 
In turn, low T may have several effects. First, it has a protective 
effect on mitochondria.34 It tends to increase local blood ﬂow, and 
reduces the temperature-dependent release of oxygen from 
hemoglobin. Hypothermia reduces cerebral glucose and oxygen 
metabolism, but maintains a slightly better energy level, which 
indicates that ATP breakdown is reduced more than ATP 
synthesis.35 
Neurons are among the most metabolically active cells, and 
most of the ATP generated is used for impulse generation and 
transmission. An estimated 40% to 50% of the energy goes to 
maintain membrane potential by driving the membrane sodium– 
potassium ATPase pump,4     while the remaining energy is 
consumed for synaptic transmission, calcium homeostasis, and 
other cellular processes including axonal transport. Because 
neuronal activity, CMRO , ATP content, and T are tightly 
linked,4,11 the ﬁndings of low ATP content and low T in light 
of previous reports of reduced CMRO2
32–34 suggest that neuronal 
activity is reduced at rest in patients with mitochondrial diseases. 
This ﬁnding might help to explain the brain dysfunction and 
symptoms observed in patients with lower Tbr. 
The Tbr curve of mitochondrial patients remains substantially 
ﬂat during and after brain activation, with all values lower than the 
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Tbr in the corresponding functional states in control participants. 
Because physiologically Tbr is mainly affected by CMRO2 during 
functional challenges, this ﬁnding suggests that the defective 
respiratory chain, beyond underfunctioning at rest, cannot 
increase CMRO      any further in response to increased 
demands,36 which also seems to be conﬁrmed in our study by 
decreased high-energy phosphate content during the post-
activation phase. In the normal brain, high-energy phosphates 
(which contain energy used for brain functioning) are mostly 
synthesized through oxidative pathways, with the ratio of oxygen 
use to glucose use maximally increased during the postactivation 
phase compared with activation and rest.37,38 These ﬁndings also 
suggest that neurons most likely do not activate appropriately 
during brain stimulation in individuals with mitochondrial diseases 
as suggested by the ﬁnding of abnormal pattern reversal visual-
evoked potentials in these patients. These considerations may 
have important implications when studying brain activation and 
brain functions in patients with mitochondrial dysfunction.36 
  
